Description
A marker sometimes used to aid in the identification and stratification of individuals at risk for future cardiovascular disease, similar to other inflammatory markers like C-Reactive Protein. GlycA, however, is a composite biomarker that integrates the protein levels and glycosylation states of several of the most abundant acute-phase proteins in serum allowing for a more stable measure of systemic inflammation.